December 2025
1. TIEW PY, Narayana JK, Jaggi TK, Koh MS, et al
   Aspergillus fumigatus sensitization is associated with high-risk bronchiectasis.
   Chest. 2025 Dec 10:S0012-3692(25)05826-X. doi: 10.1016/j.chest.2025.
   

   >> Share

   
   September 2025
2. SINHA P, Karoly M, Padmapriyadarsini C, Paradkar M, et al
   Contribution of Key Comorbidities to Unfavorable Treatment Outcomes among Adults with Drug-sensitive Pulmonary Tuberculosis in India: a Prospective Cohort Analysis.
   Chest. 2025 Sep 10:S0012-3692(25)05171-2. doi: 10.1016/j.chest.2025.
   

   >> Share

   
   July 2025
3. CHEN C, Xue H, Horsburgh CR, Amour M, et al
   Trajectories of Interferon-Gamma Release Assay Results Over 2 Years in Independent Cohorts From China, South Africa, Tanzania, and the United States.
   Chest. 2025;168:33-42.
   

   >> Share

   
   May 2025
4. JIANG J, Rao Y, Liu C, Chang SJ, et al
   A 7-Year-Old Girl With Multiple Pulmonary Nodules.
   Chest. 2025;167:e161-e165.
   

   >> Share

   
   
5. DONOVAN FM, Thompson GR 3rd, Blair JE, Johnson RH, et al
   Managing Cavitary Coccidioidomycosis Expert Opinions for Improving Patient Outcomes.
   Chest. 2025;167:1311-1320.
   

   >> Share

   
   April 2025
6. AGARWAL R, Muthu V, Sehgal IS
   Evaluation for Allergic Bronchopulmonary Aspergillosis in Patients With Bronchiectasis.
   Chest. 2025;167:e143.
   

   >> Share

   
   
7. CARTER C, Shah A
   The Fungal Frontier: Understanding the Impact of Aspergillus in Bronchiectasis.
   Chest. 2025;167:914-916.
   

   >> Share

   
   March 2025
8. LEE J, Park SJ, Kim S, Lee HN, et al
   Isolation of Genetically Distinct Strains Within the Same Species During Treatment of Mycobacterium Avium Complex Pulmonary Disease.
   Chest. 2025;167:675-685.
   

   >> Share

   
   February 2025
9. JAIN R, Peng G, Lee M, Keller A, et al
   Impact of Cystic Fibrosis Transmembrane Conductance Regulator Modulators on Maternal Outcomes During and After Pregnancy.
   Chest. 2025;167:348-361.
   

   >> Share

   
   
10. WAHAB A, Sanborn D, Vergidis P, Razonable R, et al
    Diagnosis and Prevention of Invasive Fungal Infections in the Immunocompromised Host.
    Chest. 2025;167:374-386.
    

    >> Share

    
    January 2025
11. KIM H, Jo E, Kim J, Lee N, et al
    Diagnostic Performance of the Modified Lung-RADS in a Tuberculosis-endemic Country: The Korean National Lung Cancer Screening Program.
    Chest. 2025 Jan 28:S0012-3692(25)00133-3. doi: 10.1016/j.chest.2025.
    

    >> Share

    
    
12. JIANG Y, Huang X, Zhou H, Wang M, et al
    Clinical Characteristics and Prognosis of Patients With Severe Pneumonia With Pneumocystis jirovecii Colonization: A Multicenter, Retrospective Study.
    Chest. 2025;167:54-66.
    

    >> Share

    
    December 2024
13. EVEN-DAR R, Raz I, Brodsky M, Stein N, et al
    Non- Tuberculous mycobacterial infection and pulmonary disease In Northern Israel: a focus on M. simiae.
    Chest. 2024 Dec 2:S0012-3692(24)05600-9. doi: 10.1016/j.chest.2024.
    

    >> Share

    
    November 2024
14. HOLTROP M, Cosmich S, Lee M, Keller A, et al
    Sex Differences After Treatment With Ivacaftor in People With Cystic Fibrosis.
    Chest. 2024;166:951-962.
    

    >> Share

    
    October 2024
15. CHOI H, Hughes C, Eke Z, Shuttleworth M, et al
    Clinical Efficacy of Serum Anti-glycopeptidolipid-core IgA Antibody Test for Screening Nontuberculous Mycobacterial Pulmonary Disease in Bronchiectasis: A European Multicenter Cohort Study.
    Chest. 2024 Oct 25:S0012-3692(24)05418-7. doi: 10.1016/j.chest.2024.
    

    >> Share

    
    
16. POLLOCK J, Goeminne PC, Aliberti S, Polverino E, et al
    Aspergillus serology and clinical outcomes in patients with bronchiectasis: data from the European Bronchiectasis Registry (EMBARC).
    Chest. 2024 Oct 24:S0012-3692(24)05400-X. doi: 10.1016/j.chest.2024.06.3843.
    

    >> Share

    
    
17. GABORIT B, Lecuyer R, Issa N, Camou F, et al
    Should We Reconsider Pneumocystis Pneumonia Presentation and Treatment According to Its Underlying Disease?: An Unsupervised Cluster Analysis of a Retrospective Multicenter Study.
    Chest. 2024;166:708-711.
    

    >> Share

    
    
18. JOEAN O, von Eynern LP, Welte T, Einecke G, et al
    Clinical Features, Diagnostics, Etiology, and Outcomes of Hospitalized Solid Organ Recipients With Community-Acquired Pneumonia: A Retrospective Cohort Analysis.
    Chest. 2024;166:697-707.
    

    >> Share

    
    September 2024
19. LEE JK, Kim S, Chong YP, Lee HJ, et al
    The Association Between Sputum Culture Conversion and Mortality in Cavitary Mycobacterium avium Complex Pulmonary Disease.
    Chest. 2024;166:442-451.
    

    >> Share

    
    
20. HYUNG K, Kim SA, Kim JY, Kwak N, et al
    Rates and Risk Factors of Progression in Patients With Nontuberculous Mycobacterial Pulmonary Disease: Secondary Analysis of a Prospective Cohort Study.
    Chest. 2024;166:452-460.
    

    >> Share

    
    August 2024
21. PEDERSEN AA, Lokke A, Floe A, Ibsen R, et al
    Nationwide Increasing Incidence of Nontuberculous Mycobacterial Diseases Among Adults in Denmark: Eighteen Years of Follow-Up.
    Chest. 2024;166:271-280.
    

    >> Share

    
    July 2024
22. BAI AD, Srivastava S, Digby GC, Girard V, et al
    Anaerobic Antibiotic Coverage in Aspiration Pneumonia and the Associated Benefits and Harms: A Retrospective Cohort Study.
    Chest. 2024;166:39-48.
    

    >> Share

    
    
23. FELZER JR, Montgomery AJ, LeMahieu AM, Finney Rutten LJ, et al
    Disparities in Influenza, Pneumococcal, COVID-19 Vaccine Coverage in High-Risk Adults Aged 19 to 64 Years in Southeastern Minnesota, 2010-2021.
    Chest. 2024;166:49-60.
    

    >> Share

    
    June 2024
24. SCHERGER SJ, Kalil AC
    Changes in the Mortality Rate and Epidemiology of Pneumocystis Pneumonia Require Novel Approaches to Clinical Care.
    Chest. 2024;165:1273-1275.
    

    >> Share

    
    
25. LECUYER R, Issa N, Camou F, Lavergne RA, et al
    Characteristics and Prognosis Factors of Pneumocystis jirovecii Pneumonia According to Underlying Disease: A Retrospective Multicenter Study.
    Chest. 2024;165:1319-1329.
    

    >> Share

    
    May 2024
26. ZWEIJPFENNING SMH, Aarnoutse R, Boeree MJ, Magis-Escurra C, et al
    Safety and Efficacy of Clofazimine as an Alternative for Rifampicin in Mycobacterium avium Complex Pulmonary Disease Treatment: Outcomes of a Randomized Trial.
    Chest. 2024;165:1082-1092.
    

    >> Share

    
    March 2024
27. WALKER MK, Kadri SS
    Generalizing the Use of a Procalcitonin-Guided Antibiotic Algorithm to a New Era of SARS-CoV-2 Infection.
    Chest. 2024;165:e85-e86.
    

    >> Share

    
    
28. THIZY G, Flahault A, Scemla A, Roux O, et al
    Legionnaires Disease in Solid Organ Transplant Recipients: A Decade-Long Nationwide Study in France.
    Chest. 2024;165:507-520.
    

    >> Share

    
    
29. YAN M, Fraser B, McArthur E, Mehrabi M, et al
    External Validation of the BACES Score in Canadian Patients With Nontuberculous Mycobacterial Pulmonary Disease.
    Chest. 2024;165:521-528.
    

    >> Share

    
    
30. AZAR MM
    A Diagnostic Approach to Fungal Pneumonia: An Infectious Diseases Perspective.
    Chest. 2024;165:559-572.
    

    >> Share

    
    December 2023
31. NAEGER S, Pool V, Macina D
    Increased burden of pertussis among adolescents and adults with asthma or COPD in the US, 2007-2019.
    Chest. 2023 Dec 19:S0012-3692(23)05934-2. doi: 10.1016/j.chest.2023.
    

    >> Share

    
    
32. KU JH, Henkle E, Carlson KF, Marino M, et al
    Tolerability outcomes of ATS/IDSA guideline-recommended multi-drug antibiotic treatment for Mycobacterium avium complex pulmonary disease in U.S. Medicare beneficiaries with bronchiectasis.
    Chest. 2023 Dec 10:S0012-3692(23)05846-4. doi: 10.1016/j.chest.2023.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share